Sun Pharma Advanced Research Company Ltd Sparcis A Clinical Stage Biopharmaceutical Company Based In Mumbaiindiaestablished In 2006 As A Subsidiary Of Sun Pharmaceutical Industries Ltd Sparc Focuses On Developing Innovative Therapeutics For Complex Medical Conditionsthe Company Is Dedicated To Research And Developmentparticularly In Oncologyimmunologyand Neurodegeneration Sparc S Pipeline Includes A Range Of Candidatessuch As Vodobatiniba Bcr Abl Inhibitor In Phase 2 Trials For Refractory Chronic Myelogenous Leukemiaand Vibozilimoda Selective S1Pr1 Agonist In Phase 2 Trials For Psoriasis And Atopic Dermatitisthe Company Also Explores Treatments For Neurodegenerative Diseasesincluding Parkinson S Diseasesparc Collaborates With Regulatory Bodies And Pharmaceutical Partners To Advance Its Drug Development Effortsleveraging The Resources And Expertise Of Its Parent Companysun Pharma
